retatrutide effects clinical trial Today, we shared new data from two Phase 3 trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Introducing Retatrutide — the next-gen,

Some of the common ones are: Nausea Headache Stomach pain Heartburn Dizziness Mood changes Experts say its important for people prescribed GLP-1 medications to recognize that the drugs are part of a long-term treatment plan that involves lifestyle factors such as a balanced, healthy diet and regular aerobic and strength exercise

8% hit plateau before week 36 then maintained successfully

Improvements in cardiovascular risk markers, including cholesterol, triglycerides, and blood pressure, were also observed

Most Canadians dont eat enough fibre, yet its one of the most powerful nutrients for improving fullness, blood sugar control, digestive health, and long-term metabolic health

I DO NOT recommend anything I havent personally researched inside and out

Sassoon, D